[
  {
    "ts": "2026-01-27T04:35:19+00:00",
    "headline": "2 Profitable Stocks to Own for Decades and 1 Facing Headwinds",
    "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
    "url": "https://finance.yahoo.com/news/2-profitable-stocks-own-decades-043519460.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "043bb5ef-7cd2-329c-8c23-7da6a6d0324e",
      "content": {
        "id": "043bb5ef-7cd2-329c-8c23-7da6a6d0324e",
        "contentType": "STORY",
        "title": "2 Profitable Stocks to Own for Decades and 1 Facing Headwinds",
        "description": "",
        "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
        "pubDate": "2026-01-27T04:35:19Z",
        "displayTime": "2026-01-27T04:35:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/f4fa93632eac2e69a798f8bbc28c73ed",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ELAN Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zGki2oQwdsi5AtPQ6WPOgw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/f4fa93632eac2e69a798f8bbc28c73ed.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8.iQjA71SyKK_Hvu6ml9xg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/f4fa93632eac2e69a798f8bbc28c73ed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-profitable-stocks-own-decades-043519460.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-profitable-stocks-own-decades-043519460.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELAN"
            },
            {
              "symbol": "EEFT"
            },
            {
              "symbol": "FOUR"
            },
            {
              "symbol": "FOUR-PA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T13:38:52+00:00",
    "headline": "Eli Lilly (LLY) Oncology Pipeline and $1B Nvidia (NVDA) AI Partnership Signal Strong 2026 Growth",
    "summary": "Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold in 2026. On January 20, Eli Lilly received FDA Breakthrough Therapy designation for sofetabart mipitecan. This status applies to the treatment of adults with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer whose disease has progressed despite prior therapies. […]",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-oncology-pipeline-133852697.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "2793d3c2-a111-3119-a03f-495f70d549b7",
      "content": {
        "id": "2793d3c2-a111-3119-a03f-495f70d549b7",
        "contentType": "STORY",
        "title": "Eli Lilly (LLY) Oncology Pipeline and $1B Nvidia (NVDA) AI Partnership Signal Strong 2026 Growth",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold in 2026. On January 20, Eli Lilly received FDA Breakthrough Therapy designation for sofetabart mipitecan. This status applies to the treatment of adults with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer whose disease has progressed despite prior therapies. […]",
        "pubDate": "2026-01-27T13:38:52Z",
        "displayTime": "2026-01-27T13:38:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/101b148d88f043f017180ca8b31d9a4a",
          "originalWidth": 1920,
          "originalHeight": 1281,
          "caption": "Eli Lilly (LLY) Oncology Pipeline and $1B Nvidia (NVDA) AI Partnership Signal Strong 2026 Growth",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/klOIJuPmSNUuqUttRqYcyw--~B/aD0xMjgxO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/101b148d88f043f017180ca8b31d9a4a.cf.webp",
              "width": 1920,
              "height": 1281,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NNO5eYVXOnUsR4MHY_ZoVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/101b148d88f043f017180ca8b31d9a4a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-oncology-pipeline-133852697.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-oncology-pipeline-133852697.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]